Cabergoline for Ovarian Hyperstimulation: A Review of Clinical Evidence
Ruchika Garg, Meenal Jain
Citation Information :
Garg R, Jain M. Cabergoline for Ovarian Hyperstimulation: A Review of Clinical Evidence. J South Asian Feder Obs Gynae 2015; 7 (1):30-32.
Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome. Hum Reprod update 2008;4:321-333.
Dopamine agonist cabergoline reduces hemoconcentration in hyperstimulated women undergoing assisted reproduction. J Clin endocrinal Metab 2007. p. 922931-922937.
How to avoid ovarian hyperstimulation syndrome: a new indication for dopamine agonists. Reprod Biomed Online 2009;18:71-75.
Cabergoline influences ovarian hyperstimulation in hyperprolactemic patient with polycystic ovary syndrome. Hum Reprod 2001;16:2263-2266.
Thromboembolic phenomenon after ovarian stimulation with human menopausal gonadotropin. Lanut 1965;2:1213-1215.
Ovarian hyperstimulation in novel reproductive technologies; prevention and treatment. Fertil Stenil 1992;58249-58261.
The ovarian hyperstimulation syndrome. In: adashi EY, Rock JA, Rosenwakes, editors. Reproductive endocrinology, surgery and technology. Philadelphia, Lippincott-Raven Pub 1996. p. 2225-2232.
Ovarian-hyperstimulation-syndrome epidemiology, pathophysiology, prevention and management. 1st ed. New York: Cambridge University Press 2006. p. 10-33.
Fisher O Inslier Y. Recurrent spontaneous ovarian hyperstimulation syndrome associated with PCOS. Gynecol Endometrial 1995; 9:313-315.
Ovarian hyperstimulation associated with a spontaneous pregnancy. J Obstet Gynaecol 2005;25:394-395.
Weinraub Hyperstimulation syndrome. An update review Obstet Gynecol Surv 1989;44:430-440.
Gerkan, Lali karakocsokmensuer-prevention OHSS: cabergoline versus coasting. Archies of Gynaecol Obstet 2013;288:1159-1163.
The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome. Hum Reprod Update 1997;3:255-266.
Dopamine Agonist cabergolin reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction. J Clin Endocrinal Metab 2007;92: 2931-2937.
The role of hCG or GnRH-a for prevention of severe OHSS in ART programs Middle East Fertility Society J 2000;5:73-75.
Cabergoline for the prevention of ovarian hyperstimulation syndrome: systematic review and meta-analysis of randomized controlled trial. Am Society of Reproduct Med 2013.
Youssef MA. Can dopamine agonist at a low dose reduce ovarian hyperstimulation syndrome in women at risk undergoing ICSI treatment cycles? A randomized controlled study. Eur J Obstet Gynecol Reprod Biol 2012;165:254-258.
A comparison of cabergolin and intravenous albumin in the prevention of ovarian hyperstimulation syndrome a randomized controlled trial. J Assist Reprod Genet 2012;29:259-264.